News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
435,172 Results
Type
Article (38668)
Company Profile (73)
Press Release (396427)
Multimedia
Podcasts (77)
Webinars (7)
Section
Business (116601)
Career Advice (1415)
Deals (24538)
Drug Delivery (108)
Drug Development (62952)
Employer Resources (108)
FDA (10772)
Job Trends (9396)
News (219725)
Policy (26199)
Tag
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (2030)
Accelerated approval (30)
Adcomms (27)
Allergies (108)
Alliances (42973)
ALS (144)
Alzheimer's disease (1631)
Antibody-drug conjugate (ADC) (249)
Approvals (10908)
Artificial intelligence (359)
Autoimmune disease (101)
Automation (23)
Bankruptcy (241)
Best Places to Work (7919)
BIOSECURE Act (16)
Biosimilars (153)
Biotechnology (51)
Bladder cancer (115)
Brain cancer (65)
Breast cancer (454)
Cancer (3620)
Cardiovascular disease (288)
Career advice (1205)
Career pathing (25)
CAR-T (195)
CDC (53)
Cell therapy (537)
Cervical cancer (26)
Clinical research (53106)
Collaboration (1446)
Company closure (3)
Compensation (977)
Complete response letters (58)
COVID-19 (2630)
CRISPR (66)
C-suite (437)
Cystic fibrosis (88)
Data (4609)
Decentralized trials (1)
Denatured (12)
Depression (117)
Diabetes (392)
Diagnostics (3893)
Digital health (26)
Diversity (8)
Diversity, equity & inclusion (34)
Drug discovery (195)
Drug pricing (177)
Drug shortages (31)
Duchenne muscular dystrophy (191)
Earnings (43825)
Editorial (56)
Employer branding (13)
Employer resources (101)
Events (51636)
Executive appointments (470)
FDA (13103)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (8)
Frontotemporal dementia (21)
Funding (984)
Gene editing (145)
Generative AI (34)
Gene therapy (488)
GLP-1 (956)
Government (4424)
Grass and pollen (6)
Guidances (307)
Healthcare (12072)
HIV (49)
Huntington's disease (41)
IgA nephropathy (64)
Immunology and inflammation (189)
Immuno-oncology (45)
Indications (74)
Infectious disease (2884)
Inflammatory bowel disease (118)
Inflation Reduction Act (11)
Influenza (109)
Intellectual property (170)
Interviews (250)
IPO (10760)
IRA (46)
Job creations (1799)
Job search strategy (1010)
JPM (46)
Kidney cancer (10)
Labor market (51)
Layoffs (358)
Leadership (23)
Legal (7133)
Liver cancer (68)
Longevity (14)
Lung cancer (511)
Lymphoma (288)
Machine learning (32)
Management (35)
Manufacturing (566)
MASH (137)
Medical device (6669)
Medtech (6694)
Mergers & acquisitions (14635)
Metabolic disorders (1090)
Multiple sclerosis (134)
NASH (20)
Neurodegenerative disease (293)
Neuropsychiatric disorders (81)
Neuroscience (2720)
Neurotech (1)
NextGen: Class of 2026 (3863)
Non-profit (2996)
Now hiring (9)
Obesity (558)
Opinion (247)
Ovarian cancer (108)
Pain (125)
Pancreatic cancer (180)
Parkinson's disease (263)
Partnered (24)
Patents (334)
Patient recruitment (313)
Peanut (43)
People (27219)
Pharmaceutical (20)
Pharmacy benefit managers (20)
Phase 1 (16169)
Phase 2 (23174)
Phase 3 (18429)
Pipeline (3950)
Policy (273)
Postmarket research (1932)
Preclinical (6885)
Press Release (28)
Prostate cancer (175)
Psychedelics (44)
Radiopharmaceuticals (239)
Rare diseases (665)
Real estate (2703)
Recruiting (48)
Regulatory (18360)
Reports (24)
Research institute (1855)
Resumes & cover letters (210)
Rett syndrome (26)
RNA editing (10)
RSV (80)
Schizophrenia (133)
Series A (142)
Series B (112)
Service/supplier (3)
Sickle cell disease (61)
Special edition (12)
Spinal muscular atrophy (156)
Sponsored (29)
Startups (2025)
State (1)
Stomach cancer (13)
Supply chain (79)
Tariffs (71)
The Weekly (64)
Vaccines (1018)
Venture capital (63)
Weight loss (385)
Women's health (54)
Worklife (14)
Date
Today (5)
Last 7 days (388)
Last 30 days (1478)
Last 365 days (20574)
2026 (1845)
2025 (20860)
2024 (23519)
2023 (26588)
2022 (34856)
2021 (37459)
2020 (35395)
2019 (29298)
2018 (22171)
2017 (21155)
2016 (19774)
2015 (22698)
2014 (16989)
2013 (14051)
2012 (14756)
2011 (15301)
2010 (13896)
Location
Africa (605)
Alabama (50)
Alaska (3)
Arizona (133)
Arkansas (6)
Asia (28080)
Australia (5136)
California (7122)
Canada (2160)
China (801)
Colorado (280)
Connecticut (315)
Delaware (240)
Europe (67497)
Florida (1084)
Georgia (237)
Hawaii (4)
Idaho (33)
Illinois (507)
India (47)
Indiana (341)
Iowa (17)
Japan (345)
Kansas (79)
Kentucky (26)
Louisiana (17)
Maine (34)
Maryland (982)
Massachusetts (5110)
Michigan (167)
Minnesota (259)
Mississippi (2)
Missouri (77)
Montana (23)
Nebraska (11)
Nevada (75)
New Hampshire (27)
New Jersey (2089)
New Mexico (17)
New York (2067)
North Carolina (825)
North Dakota (6)
Northern California (3547)
Ohio (197)
Oklahoma (10)
Oregon (17)
Pennsylvania (1427)
Puerto Rico (12)
Rhode Island (20)
South America (835)
South Carolina (32)
South Dakota (1)
Southern California (2784)
Tennessee (85)
Texas (999)
United States (25230)
Utah (164)
Vermont (1)
Virginia (179)
Washington D.C. (46)
Washington State (583)
West Virginia (2)
Wisconsin (65)
Wyoming (2)
435,172 Results for "brain ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Insights
The New Gold Rush in Brain Science
Fueled by advances in biomarkers, brain mapping, and AI, investment in neuro and CNS innovation shows no signs of slowing, even amid costly setbacks.
BioSpace
spoke to investors at JPM26 to get their take on recent bets in new therapies and neurotech.
January 22, 2026
·
5 min read
·
Jennifer Smith-Parker
Press Releases
Timeline Continues to Build the Most Clinically Researched Longevity Products Targeting Immune, Brain and Muscle Aging
November 3, 2025
·
4 min read
Press Releases
CMUH-Ever Supreme Team Develops World-First Brain-Targeting Exosome Delivering Curcumin Across the Blood-Brain Barrier for Parkinson’s Disease
January 29, 2026
·
5 min read
Press Releases
Lysoway Therapeutics Announces Phase I Readiness of Brain-Penetrant TRPML1 Agonist LW-1017 and Nomination of a TMEM175 Development Candidate
January 6, 2026
·
4 min read
Press Releases
Researchers Find Brain Mechanism Behind ‘Flashes of Intuition’
February 4, 2026
·
6 min read
Press Releases
KeifeRx Announces Research Collaboration and Option Agreement with Amneal Pharmaceuticals to Advance KFRX06, a Brain-Penetrant LRRK2 Program for Parkinson’s Disease
January 12, 2026
·
3 min read
Neurodegenerative disease
VectorY Bets up to $1.2B+ That Shape’s Brain-Penetrant Capsids Are a Fit
VectorY Therapeutics will evaluate the use of SHP-DB1, a capsid developed by Shape Therapeutics, to deliver therapies to the brain, including VectorY’s developmental Huntington’s and Alzheimer’s disease treatments.
September 18, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21
November 13, 2025
·
7 min read
Opinion
Bringing Neurological Disease Into the Age of Precision Medicine
To more effectively treat neurodegenerative conditions, we first need diagnostic tools that lend a more complete picture of protein aggregates in the brain.
May 12, 2025
·
5 min read
·
John McDonough
Press Releases
Moleculin Announces New Annamycin Collaboration in Brain Tumors
December 8, 2025
·
6 min read
1 of 43,518
Next
